Share
Market Research Report

NORTH AMERICA SYNTHETIC OPIOIDS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeSynthetic Opioids (Methadone, Fentanyl, and Meperidine) · and Semi Synthetic Opioids (Hydrocodane, Oxymorphone, Oxycodone, Hydromorphone, and Buprenorphine)
  • By ApplicationPain Management and De-Addiction
  • By Distribution ChannelRetail Outlets and Hospitals
  • By GeographyU.S. and Canada
  • Published In31 Mar 2026
  • Report CodeCMI3660
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Country
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product Launches
    • Technological Advancements
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. North America Synthetic Opioids Market, By Product Type, 2021–2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Synthetic Opioids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
        • Methadone
        • Fentanyl
        • Meperidine
    • Semi Synthetic Opioids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
        • Hydrocodane
        • Oxymorphone
        • Oxycodone
        • Hydromorphone
        • Buprenorphine
  5. North America Synthetic Opioids Market, By Application, 2021–2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Pain Management     
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • De-Addiction
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  6. North America Synthetic Opioids Market, By Distribution Channel, 2021–2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segments Trends
    • Retail Outlets
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  7. North America Synthetic Opioids Market, By Country, 2021–2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, By Country, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2022–2033
      • Country Trends
    • U.S.
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021–2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Billion)
    • Canada
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021–2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021–2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021–2033, (US$ Billion)
  8. Competitive Landscape

    • Johnson & Johnson Services, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Purdue Pharma L.P.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Hikma Pharmaceuticals PLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sun Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AstraZeneca Plc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mallinckrodt Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Endo Pharmaceuticals Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boehringer Ingelheim International GmbH.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  9. Section

    • Research Methodology
    • About Us